Wednesday, June 10, 2026

Drug profile · INN

mesna

mesna (UROMITEXAN) is a unknown. Associated with BAXTER HEALTHCARE PTY LTD. Route of administration: oral. Current US regulatory status: approved.

FDA: approved TGA: approved
US status approved
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — mesna
US status
approved
Class
Route
ORAL
Patents
0
Programs
4
Data quality
0.89

Quick answer

mesna (UROMITEXAN) is a unknown. Associated with BAXTER HEALTHCARE PTY LTD. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN mesna
Brand UROMITEXAN
Mechanism Unknown
Route ORAL
Formulation INJECTABLE

Mechanism of action

Unknown

Approval history

Authority Status Date
FDA approved
TGA approved

Pipeline programs

  1. IOV-MEL-301 Phase 3 · Iovance Biotherapeutics · Melanoma
  2. APHP230701 Phase 2 · PARItec · paraneoplastic sensory neuropathy with anti-Hu antibodies
  3. KTE-C19-102 Phase 2 · Anaxis Pharma · Relapsed/Refractory Mantle Cell Lymphoma
  4. UC_0160/1406 Phase 2 · Ningbo Cancer Hospital · Penis carcinoma

Frequently asked questions

What is mesna?

mesna (UROMITEXAN) is a unknown. Associated with BAXTER HEALTHCARE PTY LTD. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for mesna?

UROMITEXAN is a marketed brand name for mesna. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of mesna?

mesna has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.